AmSurg (AMSG) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings	283.4M
Depreciation and amortization	90.71M
Net loss on sale of long-lived assets
Share-based compensation
Excess tax benefit from share-based compensation	-3.91M
Deferred income taxes	34.61M
Accounts receivable, net	-387.73M
Supplies inventory	-699K
Prepaid and other current assets	-16.12M
Accounts payable	-5.62M
Accrued expenses and other liabilities	-14.42M
Other, net	11.63M
Net cash flows provided by operating activities	351.09M
Acquisition of interests in surgery centers and related transactions	-351.74M
Acquisition of property and equipment	-64.01M
Proceeds from sale of interests in surgery centers
Net cash flows used in investing activities	-388.33M
Proceeds from long-term borrowings	430.01M
Repayment on long-term borrowings	-214.27M
Distributions to noncontrolling interests	-172.08M
Proceeds from issuance of common stock upon exercise of stock options	450K
Repurchase of common stock	-6.15M
Capital contributions and ownership transactions by noncontrolling interests
Excess tax benefit from share-based compensation
Financing cost incurred
Net cash flows used in financing activities	36.64M
Net decrease in cash and cash equivalents	-602K
Cash and cash equivalents, beginning of period	106.66M
Cash and cash equivalents, end of period	106.06M

Entities mentioned with AMSG

View All Entities